We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYXS icon
4201
Pyxis Oncology
PYXS
$191M
$11K ﹤0.01%
2,623
+1,960
+296% +$14.3K
REFI
4202
Chicago Atlantic Real Estate Finance
REFI
$260M
$11K ﹤0.01%
+605
New +$11.2K
RELX icon
4203
RELX
RELX
$60B
$11K ﹤0.01%
345
-4,902
-93% -$148K
RGP icon
4204
Resources Connection
RGP
$145M
$11K ﹤0.01%
624
-194
-24% -$3.33K
SHV icon
4205
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
$11K ﹤0.01%
+100
New +$11K
HTO
4206
H2O America
HTO
$2.67B
$11K ﹤0.01%
158
-370
-70% -$24.9K
FTH
4207
Faeth Therapeutics
FTH
$836M
$11K ﹤0.01%
238
+57
+31% +$4.54K
SRCE icon
4208
1st Source
SRCE
$2.13B
$11K ﹤0.01%
238
-225
-49% -$11.1K
STTK icon
4209
Shattuck Labs
STTK
$745M
$11K ﹤0.01%
2,514
-1,997
-44% -$11.3K
SUPN icon
4210
Supernus Pharmaceuticals
SUPN
$2.81B
$11K ﹤0.01%
346
-2,843
-89% -$87.2K
SWAG icon
4211
Stran & Co
SWAG
$35.4M
$11K ﹤0.01%
6,201
+4,095
+194% +$10.3K
SXC icon
4212
SunCoke Energy
SXC
$794M
$11K ﹤0.01%
1,239
-19,162
-94% -$151K
TCBX icon
4213
Third Coast Bancshares
TCBX
$768M
$11K ﹤0.01%
464
+169
+57% +$4.03K
TCRT icon
4214
Alaunos Therapeutics
TCRT
$4.71M
$11K ﹤0.01%
114
+31
+37% +$3.98K
TERN
4215
DELISTED
Terns Pharmaceuticals
TERN
$11K ﹤0.01%
3,556
+2,013
+130% +$8.59K
TGS icon
4216
Transportadora de Gas del Sur
TGS
$4.23B
$11K ﹤0.01%
1,595
+198
+14% +$1.05K
TW icon
4217
Tradeweb Markets
TW
$22.4B
$11K ﹤0.01%
120
-1,294
-92% -$112K
UBCP icon
4218
United Bancorp
UBCP
$88.6M
$11K ﹤0.01%
590
-67
-10% -$1.16K
ULBI icon
4219
Ultralife
ULBI
$125M
$11K ﹤0.01%
2,036
+1,536
+307% +$8.22K
UMH
4220
UMH Properties
UMH
$1.4B
$11K ﹤0.01%
467
-124
-21% -$2.98K
UVSP icon
4221
Univest Financial
UVSP
$1.19B
$11K ﹤0.01%
408
-180
-31% -$5.29K
WLYB icon
4222
John Wiley & Sons Class B
WLYB
$2.61B
$11K ﹤0.01%
213
+101
+90% +$5.38K
ORKA
4223
Oruka Therapeutics
ORKA
$7.35B
$11K ﹤0.01%
413
+223
+117% +$5.53K
SPRB
4224
Spruce Biosciences
SPRB
$151M
$11K ﹤0.01%
71
+5
+8% +$930
FNA
4225
DELISTED
Paragon 28, Inc.
FNA
$11K ﹤0.01%
635
-5,091
-89% -$82K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.